Neurocrine Biosciences Market Sentiment

Neurocrine Biosciences Inc

NBIXNASDAQ

Trade with Public

$138.35

-2.09-1.49%

近くで: Sep 28, 5:00 PM EST

$138.00

-2.44-1.74%

プレマーケット: 8:29 AM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Neurocrine Biosciences Market Sentiment

Market sentiment signals for Neurocrine Biosciences (NBIX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 6.4% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

26 analysts

Options Flow (P/C)

—

Avg Consensus PT

$200

+44.9%

Highest Price Target

$253

+83.3%

Citigroup

Lowest Price Target

$160

+15.9%

Wolfe Research

Short Interest

6.4%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 29, 2026	UBS	Ashwani Verma—	+55.1%	$231 → $214	Maintained	Buy
Sep 11, 2026	Morgan Stanley	Jeffrey Hung—	+32.6%	$182 → $183	Maintained	Equal-Weight
Sep 8, 2026	RBC Capital	Brian Abrahams—	+43.5%	$198 → $198	Maintained	Outperform
Sep 3, 2026	Citigroup	Yigal Nochomovitz—	+83.3%	$249 → $253	Maintained	Buy
Aug 13, 2026	Morgan Stanley	Jeffrey Hung—	+31.9%	$196 → $182	Maintained	Equal-Weight
Aug 3, 2026	Canaccord Genuity	Sumant Kulkarni—	+52.2%	$200 → $210	Maintained	Buy
Aug 3, 2026	Truist Securities	Danielle Brill—	+54.3%	$200 → $213	Maintained	Buy
Aug 3, 2026	Wedbush	Laura Chico—	+40.6%	$185 → $194	Maintained	Outperform
Jul 31, 2026	Citigroup	Yigal Nochomovitz—	+80.4%	$246 → $249	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	+43.5%	$195 → $198	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Jeffrey Hung—	+42.0%	$193 → $196	Maintained	Equal-Weight
Jul 31, 2026	TD Cowen	Phil Nadeau—	+59.4%	$200 → $220	Maintained	Buy
Jul 31, 2026	Piper Sandler	David Amsellem—	+52.2%	$207 → $210	Maintained	Overweight
Jul 31, 2026	Cantor Fitzgerald	Josh Schimmer—	+55.8%	$210 → $215	Maintained	Overweight
Jul 31, 2026	Guggenheim	Yatin Suneja—	+60.9%	$200 → $222	Maintained	Buy
Jul 31, 2026	Stifel	Paul Matteis—	+55.8%	$188 → $215	Maintained	Buy
Jul 31, 2026	Needham	Ami Fadia—	+47.8%	$200 → $204	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+44.9%	$175 → $200	Maintained	Buy
Jul 17, 2026	Wells Fargo	Mohit Bansal—	+44.9%	$175 → $200	Maintained	Overweight
Jul 13, 2026	Truist Securities	Danielle Brill—	+44.9%	$155 → $200	Maintained	Buy
Jul 13, 2026	BMO Capital	Evan Seigerman—	+23.2%	$144 → $170	Maintained	Market Perform
Jul 7, 2026	RBC Capital	Brian Abrahams—	+41.3%	$183 → $195	Maintained	Outperform
Jun 30, 2026	UBS	Ashwani Verma—	+50.7%	$182 → $208	Maintained	Buy
Jun 2, 2026	Goldman Sachs	Corinne Johnson—	+54.3%	$213	Reinstates	Buy
May 29, 2026	RBC Capital	Brian Abrahams—	+32.6%	$180 → $183	Maintained	Outperform